📰 Dexcom News
Page 85 - Dexcom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.
February 19, 2024
Rathbones Group PLC boosted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 10.6% during the third quarter, Holdings Channel reports. The institutional investor owned 1,262,214 shares of the medical device company’s stock after purchasing an additional 120,870 shares during the quarter. Rathbones Group PLC’s holdings in DexCom were worth $117,765,000 as of its […]
February 18, 2024
BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 100.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 141,293 shares of the medical device company’s stock after purchasing an additional 70,867 […]
February 17, 2024
Korea Investment CORP lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 20.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 458,082 shares of the medical device company’s stock after selling 119,232 shares during the quarter. Korea Investment CORP […]
February 16, 2024
StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Monday. A number of other analysts have also recently commented on the stock. Wells Fargo & Company increased their price target on shares of DexCom from $110.00 to $136.00 and gave […]
February 15, 2024
Rhumbline Advisers lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.0% in the third quarter, Holdings Channel.com reports. The firm owned 789,255 shares of the medical device company’s stock after acquiring an additional 133 shares during the quarter. Rhumbline Advisers’ holdings in DexCom were worth $73,637,000 as of its most recent SEC […]
February 14, 2024
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
February 14, 2024
Broadleaf Partners LLC grew its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 41.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,912 shares of the medical device company’s stock after buying an additional 24,642 shares during the quarter. […]
February 13, 2024
Expectations are high for companies making blood sugar monitors and business automation software.
February 13, 2024
Deutsche Bank AG lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 74.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,754,036 shares of the medical device company’s stock after selling 5,013,431 shares during the period. Deutsche Bank AG’s holdings in DexCom were worth $163,652,000 as of its most recent […]
February 11, 2024
Vectors Research Management LLC decreased its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,326 shares of the medical device company’s stock after selling 257 shares during the period. Vectors Research Management LLC’s […]